268 related articles for article (PubMed ID: 25258254)
21. The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma.
Geng M; Xiao H; Liu J; Song Y; Fu P; Cheng X; Zhang J; Wang G
Cancer Med; 2018 Aug; 7(8):3889-3898. PubMed ID: 29982995
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
[TBL] [Abstract][Full Text] [Related]
23. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma.
Rubenstein JL; Wong VS; Kadoch C; Gao HX; Barajas R; Chen L; Josephson SA; Scott B; Douglas V; Maiti M; Kaplan LD; Treseler PA; Cha S; Hwang JH; Cinque P; Cyster JG; Lowell C
Blood; 2013 Jun; 121(23):4740-8. PubMed ID: 23570798
[TBL] [Abstract][Full Text] [Related]
24. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
Ungureanu A; Le Garff-Tavernier M; Costopoulos M; Parratte T; Brinet A; Durand H; Gaultier C; Hurstel R; Alamome I; Sellal F; Ahle G
J Neurol; 2021 Aug; 268(8):2890-2894. PubMed ID: 33609156
[TBL] [Abstract][Full Text] [Related]
25. Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas.
Schroers R; Baraniskin A; Heute C; Kuhnhenn J; Alekseyev A; Schmiegel W; Schlegel U; Pels HJ
Eur J Haematol; 2010 Sep; 85(3):236-42. PubMed ID: 20528903
[TBL] [Abstract][Full Text] [Related]
26. [Magnetic resonance as initial screening diagnosis of secondary involvement of central nervous system in NHL diffuse large B cell lymphoma].
Oliver AC; Irigoin V; Sgarbi N; Peixoto A; Turcatti P; Diaz L; Zunino J
Rev Fac Cien Med Univ Nac Cordoba; 2018 Jun; 75(2):67-71. PubMed ID: 30273529
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid interleukin (IL)-10 and IL-10:IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal dissemination.
Costopoulos M; Kim R; Choquet S; Maloum K; Houillier C; Algrin C; Settegrana C; Villemonteix J; Brissard M; Quiney C; Bernard S; Davi F; Thieblemont C; Hoang-Xuan K; Leblond V; Merle-Beral H; Le Garff-Tavernier M
Semin Hematol; 2018 Oct; 55(4):179-181. PubMed ID: 30502843
[TBL] [Abstract][Full Text] [Related]
28. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
Baraniskin A; Deckert M; Schulte-Altedorneburg G; Schlegel U; Schroers R
Br J Haematol; 2012 Feb; 156(4):421-32. PubMed ID: 22077417
[TBL] [Abstract][Full Text] [Related]
29. Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome.
Muñiz C; Martín-Martín L; López A; Sánchez-González B; Salar A; Almeida J; Sancho JM; Ribera JM; Heras C; Peñalver FJ; Gómez M; González-Barca E; Alonso N; Navarro B; Olave T; Sala F; Conde E; Márquez JA; Cabezudo E; Cladera A; García-Malo M; Caballero MD; Orfao A;
Blood; 2014 Mar; 123(12):1864-9. PubMed ID: 24501214
[TBL] [Abstract][Full Text] [Related]
30. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC
Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
[TBL] [Abstract][Full Text] [Related]
32. Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.
Baraniskin A; Schroers R
CNS Oncol; 2014 Jan; 3(1):77-85. PubMed ID: 25054902
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology.
Schroers R; Baraniskin A; Heute C; Vorgerd M; Brunn A; Kuhnhenn J; Kowoll A; Alekseyev A; Schmiegel W; Schlegel U; Deckert M; Pels H
Eur J Haematol; 2010 Dec; 85(6):520-8. PubMed ID: 20727005
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma.
Alvarez R; Dupuis J; Plonquet A; Christov C; Copie-Bergman C; Hemery F; Gaillard I; El Gnaoui T; Kuhnowski F; Bedoui M; Belhadj K; Brugières P; Haioun C
Ann Oncol; 2012 May; 23(5):1274-1279. PubMed ID: 21965472
[TBL] [Abstract][Full Text] [Related]
35. [Primary central nervous system lymphoma: a case report and evaluation of the diagnostic value of IL-10 level in the cerebrospinal fluid].
Mishima T; Tsuboi Y; Enomoto T; Higuchi MA; Tsugawa J; Yamada T; Tanaka T; Tsugu H; Hayashi H; Nabeshima K
Brain Nerve; 2012 Nov; 64(11):1347-51. PubMed ID: 23131747
[TBL] [Abstract][Full Text] [Related]
36. A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.
Sromek M; Rymkiewicz G; Paziewska A; Szafron LM; Kulecka M; Zajdel M; Kulinczak M; Dabrowska M; Balabas A; Bystydzienski Z; Chechlinska M; Siwicki JK
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572608
[TBL] [Abstract][Full Text] [Related]
37. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
Murase S; Saio M; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
Cancer Lett; 1998 Oct; 132(1-2):181-6. PubMed ID: 10397472
[TBL] [Abstract][Full Text] [Related]
38. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
Chazal T; Costopoulos M; Maillart E; Fleury C; Psimaras D; Legendre P; Pineton de Chambrun M; Haroche J; Lubetzki C; Amoura Z; Legarff-Tavernier M; Cohen Aubart F
Eur J Neurol; 2019 Oct; 26(10):1274-1280. PubMed ID: 31021023
[TBL] [Abstract][Full Text] [Related]
39. Autotaxin and soluble IL-2 receptor concentrations in cerebrospinal fluids are useful for the diagnosis of central nervous system invasion caused by haematological malignancies.
Shimura T; Kurano M; Morita Y; Yoshikawa N; Nishikawa M; Igarashi K; Shimamoto S; Aoki J; Yatomi Y
Ann Clin Biochem; 2019 Mar; 56(2):240-246. PubMed ID: 30514094
[TBL] [Abstract][Full Text] [Related]
40. Potential role of CSF cytokine profiles in discriminating infectious from non-infectious CNS disorders.
Fortuna D; Hooper DC; Roberts AL; Harshyne LA; Nagurney M; Curtis MT
PLoS One; 2018; 13(10):e0205501. PubMed ID: 30379898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
